Neuropeptide Y (13-36), amide, human
CAS No. 122341-40-6
Neuropeptide Y (13-36), amide, human ( Neuropeptide Y (13-36), human )
Catalog No. M29780 CAS No. 122341-40-6
Neuropeptide Y (13-36), amide, human is a neuropeptide Y receptor agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 579 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeuropeptide Y (13-36), amide, human
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeuropeptide Y (13-36), amide, human is a neuropeptide Y receptor agonist.
-
DescriptionNeuropeptide Y (13-36), amide, human is a neuropeptide Y receptor agonist.(In Vivo):Intraventricular injections of the Y2 neuropeptide Y receptor agonist porcine Neuropeptide Y (13-36) (25-3000 pM) produces a dose-dependent increase (up to 14%; ED50=0.3 nM for overall effects and 0.97 nM for the peak effects) in mean arterial blood pressure in the awake, unrestrains male rat without affecting heart rate. Central administration of porcine Neuropeptide Y (13-36) produces marked vasodepressor and bradycardic actions in the anaesthetized α-chloralose and in the awake unrestrained male rat.
-
SynonymsNeuropeptide Y (13-36), human
-
PathwayOthers
-
TargetOther Targets
-
RecptorNeuropeptide Y receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number122341-40-6
-
Formula Weight3000.4
-
Molecular FormulaC134H207N41O36S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Aguirre JA, et al. Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci Lett. 1990 Oct 2;118(1):5-8.
molnova catalog
related products
-
Crepidiaside B
The herbs of Picris hieracioides L.
-
TC-O 9311
TC-O 9311 is a potent GPR139 agonist.
-
Dehydrocorydalin
Dehydrocorydaline exerts anti-metastatic potential via suppression of MMPs and Bcl-2 signaling in NSCLC cells.